GB994654A - Improvements in pharmaceutical compositions having anti-fatigue properties - Google Patents

Improvements in pharmaceutical compositions having anti-fatigue properties

Info

Publication number
GB994654A
GB994654A GB3673762A GB3673762A GB994654A GB 994654 A GB994654 A GB 994654A GB 3673762 A GB3673762 A GB 3673762A GB 3673762 A GB3673762 A GB 3673762A GB 994654 A GB994654 A GB 994654A
Authority
GB
United Kingdom
Prior art keywords
fatigue properties
pharmaceutical compositions
aspartate
composition
hypophosphito
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3673762A
Inventor
Pierre Desnoyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSEDRA LAB
Original Assignee
BIOSEDRA LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSEDRA LAB filed Critical BIOSEDRA LAB
Priority to GB3673762A priority Critical patent/GB994654A/en
Publication of GB994654A publication Critical patent/GB994654A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition having anti-fatigue properties comprises potassium aspartate, magnesium aspartate and pyridoxin, and optionally calcium hypophosphito-ascorbate. The composition may be in the form of tablets or an injectable solution.
GB3673762A 1962-09-27 1962-09-27 Improvements in pharmaceutical compositions having anti-fatigue properties Expired GB994654A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB3673762A GB994654A (en) 1962-09-27 1962-09-27 Improvements in pharmaceutical compositions having anti-fatigue properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3673762A GB994654A (en) 1962-09-27 1962-09-27 Improvements in pharmaceutical compositions having anti-fatigue properties

Publications (1)

Publication Number Publication Date
GB994654A true GB994654A (en) 1965-06-10

Family

ID=10390799

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3673762A Expired GB994654A (en) 1962-09-27 1962-09-27 Improvements in pharmaceutical compositions having anti-fatigue properties

Country Status (1)

Country Link
GB (1) GB994654A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009437B (en) * 2017-09-13 2019-01-15 Promopharma Α.Ε. Drinkable dihydro magnesium aspartate-containing solutions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009437B (en) * 2017-09-13 2019-01-15 Promopharma Α.Ε. Drinkable dihydro magnesium aspartate-containing solutions

Similar Documents

Publication Publication Date Title
ZA707590B (en) Improved opaque,microcellular films from latex compositions,process and composition for preparing the same
FR2063420A5 (en)
IL37411A (en) Smoking compositions and processes for improving the same
ZA713974B (en) Oxazolidinones and thiazolidi-nones and compositions comprising them
GB994654A (en) Improvements in pharmaceutical compositions having anti-fatigue properties
CA936093A (en) Synergistic composition and its use
GB987495A (en) Improvements in or relating to mould board ploughs
ZA711479B (en) Certain cycloalkylsulfenamides as prevulcanization inhibitors
GB984753A (en) Improvements in or relating to mould board ploughs
GB1110950A (en) Improvements in or relating to disc ploughs
ES415398A1 (en) Cyanophenoxyacetonitriles
ES144300U (en) Dardo, saeta and similar. (Machine-translation by Google Translate, not legally binding)
GB1197058A (en) Improvements in or relating to Packaging Trays
GB1172825A (en) Improvements in or relating to Treatment of Refractory Surfaces.
JPS5697218A (en) Fragrant composition
CA856211A (en) Sterilizing composition
ZA703663B (en) Progestational composition and process for the preparation thereof
GB1062494A (en) Improvements in or relating to implements for spreading powdered or granular materials
GB1083057A (en) Zirconium alloy
AU1093370A (en) Improvements in or relating to devices for holding the legs of animals
GB1076082A (en) Improvements in or relating to apparatus for pneumatically pulverizing material
GB977464A (en) Improvements in or relating to harrows
GB1098285A (en) 3,6-dioxo-a-nor-b-homo-steroids
GB942316A (en) Improvements in or relating to implements for spreading powdered or granular materials
GB1102696A (en) Improvements in or relating to shoe manufacture